NLSP
NLS Pharmaceutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
NLSP fundamentals
NLS Pharmaceutics (NLSP) released its earnings on May 5, 2023: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
May 5, 2023
EPS
Revenue
Revenue & Expenses
Key Indicators
NLS Pharmaceutics (NLSP) key financial stats and ratios, covering profitability, financial health, and leverage.
NLS Pharmaceutics (NLSP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
NLS Pharmaceutics (NLSP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
NLS Pharmaceutics (NLSP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does NLS Pharmaceutics (NLSP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track NLS Pharmaceutics (NLSP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did NLS Pharmaceutics’s management provide for the next earnings period? What does NLS Pharmaceutics do and what are its main business segments?What factors drove the changes in NLS Pharmaceutics’s revenue and profit?What is NLS Pharmaceutics’s latest dividend and current dividend yield?What is the revenue and EPS growth rate for NLS Pharmaceutics year over year?What were the key takeaways from NLS Pharmaceutics’s earnings call?What is NLS Pharmaceutics’s gross profit margin?Did NLS Pharmaceutics beat or miss consensus estimates last quarter?